Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.72
Delayed Data
As of May 22
 -0.03 / -4.00%
Today’s Change
0.65
Today|||52-Week Range
1.04
+2.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization45.1K42.4K37.1K28.3K
 
 
 
 
 
 
Operating ExpensesGross Income-45.1K-42.4K-37.1K-28.3K
 
 
 
 
 
General Expenses16.1M6.1M7.9M13.2M
 
 
 
 
 
Other Operating Expenses0.00431.1K0.000.00
 
 
Research And Development12.0M3.4M3.3M7.0M
 
 
 
 
 
Total Operating Expenses16.1M6.6M8.0M13.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.1M-6.6M-8.0M-13.3M
 
 
 
 
 
Extraordinary Credit4.8M663.9K0.000.00
 
 
 
Extraordinary Charge0.00-332.1K-1.4M-5.2M
 
 
 
 
Other Expenses-101.6K0.00-204.2K-206.2K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.3M-6.2M-9.5M-18.5M
 
 
 
 
 
Net Income-11.3M-6.2M-9.5M-18.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS93.0M97.1M128.6M176.1M
 
 
 
 
 
Shares To Calculate EPS Diluted93.0M97.1M128.6M176.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.06-$0.07-$0.11
 
 
 
 
 
EPS Diluted-$0.12-$0.06-$0.07-$0.11
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account